Start here if you're new
what it is
Sensient makes colors, flavors, and fragrances for packaged food, drinks, and cosmetics.
how it gets paid
Last year Sensient Tech made $1.6B in revenue. Flavors & Extracts was the main engine at $0.8B, or 49% of sales.
why it's growing
Revenue grew 3.5% last year. However, the color group segment was a meaningful contributor of growth in the third quarter, led by a 10% sales gain and significant operating income.
what just happened
Sensient missed by 24.1% last quarter, which is a bad look for a stock at 28.4x profit.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
70/100 earnings predictability — reasonably predictable
28.4x trailing p/e — priced about right
1.8% dividend yield — cash in your pocket every quarter
10.5% return on capital — nothing to write home about
xvary composite: 52/100 — below average
What they do
Sensient makes colors, flavors, and fragrances for packaged food, drinks, and cosmetics.
You do not swap a color supplier because your cereal looks a shade off. Sensient runs 75 locations in 35 countries, and 42% of sales come from outside North America. That mix makes leaving painful for your customers and sticky for you.
How they make money
$1.6B
annual revenue · their business grew +3.5% last year
Flavors & Extracts
$0.8B
+3.5%
Color
$0.6B
+10.0%
Asia Pacific
$0.2B
+3.5%
The products that matter
specialty ingredient formulation
Flavors, fragrances & colors
$1.6B revenue
it's the entire $1.6B business, and the color group alone posted 10% sales growth in the quarter. that tells you where the momentum is.
core
natural colors expansion
Natural colors
10% segment growth
management is pushing this category ahead of end-2027 regulatory deadlines, and the company says cost actions can save $8M–$10M annually while the mix shifts.
growth pocket
portfolio optimization
Synthetic color consolidation
$8M–$10M savings
since late 2023, Sensient has been consolidating underperforming synthetic color capacity. on a $1.6B base, that will not change the story alone, but it can support margins while demand stays modest.
margin lever
Key numbers
$1.6B
annual revenue
You are buying a $1.6B ingredients business, not a tiny niche lab. That size helps it stay relevant with big food and beauty buyers.
28.4x
trailing p/e
You pay 28.4 times trailing profit. That is a rich price for a business with 3.5% projected sales growth.
18.5%
operating margin
For every $100 of sales, $18.50 stays after operating costs. That cushion helps when customers push back on price.
10.5%
return on capital
Each $100 invested in the business earns $10.50 in operating profit. That is solid, but it is not cheap capital sloshing around.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 80 / 100
- long-term debt $711M (15% of capital)
- net profit margin 11.1% — keeps 11 cents of every dollar in revenue
- return on equity 14% — $0.14 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in SXT 3 years ago → it's now worth $13,760.
The index would have given you $13,920.
source: institutional data · total return
What just happened
missed estimates
Sensient missed by 24.1% last quarter, which is a bad look for a stock at 28.4x profit.
Consensus had $0.79 in EPS and $0.60 came out. Management also pointed to $8M to $10M in annual cost savings, which is what companies say when growth is doing less heavy lifting.
$1.6B
revenue
$0.60
eps
18.5%
operating margin
miss size
The 24.1% miss matters because premium-priced stocks get punished when earnings wobble.
-
operating momentum likely continued through for sensient technologies in the final stanza of 2025.since late 2023, the company successfully implemented a portfolio optimization plan, which included consolidating underperforming synthetic color production facilities.
-
management outlined annual cost savings between $8 million and $10 million last year.this has allowed the company to focus on accelerating the adoption of natural colors, particularly ahead of regulatory deadlines by year-end 2027. meanwhile, revenue growth has been modest with tariff headwinds and challenges in the north american and european food and beverage market, hurting volumes (namely in asia pacific).
-
however, the color group segment was a meaningful contributor of growth in the third quarter, led by a 10% sales gain and significant operating income growth.
-
this was driven by strength in the food and pharmaceutical colors arm.for the full year, profits likely advanced at a double-digit clip, outpacing revenue growth in the low-single-digit range. bottom-line improvement reflected productivity initiatives and a favorable mix as natural color ingredients gain traction.
-
we have raised our 2026 shareearnings call by $0.50, to $4.00.operational adjustments and the continued focus on higher-margin natural ingredients should support bottom-line growth. we think the company will continue to benefit from regulatory-driven industry shifts toward clean-label and plantbased products.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top risk is the natural-colors transition arriving before customer volumes do.
med
natural-colors transition execution
Sensient is positioning for higher demand in natural colors ahead of end-2027 regulatory deadlines. that is the growth story. if customers move slower than expected, the stock is left with a premium multiple and only modest base-business growth.
10% color-group growth is strong. it needs to stay strong enough to matter inside a $1.6B company.
med
volume softness in food and beverage
management already called out pressure in north american and european food and beverage markets, with weaker volumes in asia pacific too. on a business that grew 3.5% last year, you do not have a huge cushion for more softness.
a 10.2% net margin business can absorb some demand wobble. it cannot absorb endless wobble while keeping a 28.4x multiple.
med
tariff and input-cost pressure
tariff pressure is already in management commentary. For a global ingredient supplier, cost inflation and compliance costs squeeze the spread between what goes in and what comes out.
the recent 8.3% quarterly margin shows there is profit cushion, but not a luxurious one.
med
multiple compression without bad operations
the stock trades at $95 while the 3–5 year target midpoint sits at $87. sometimes the risk is not that the business breaks. it's that the stock already assumes the good part.
even if operations stay decent, you can get a flat stock while earnings do the catching up.
At $95.25, SXT sits about 9% above the $87 midpoint target while the business is growing 3.5% and earning a 10.2% net margin. That is a workable setup for a good company, not a forgiving setup for a miss.
source: institutional data · regulatory filings · risk analysis
Pay attention to
trend
color growth versus company growth
the color group grew 10% in the quarter while the full company grew 3.5% last year. that gap is the whole story.
metric
margin hold above the recent 8.3%
if quarterly margin keeps improving from 8.3%, the EPS story stays intact. if it fades, the valuation gets harder to defend.
calendar
end-2027 regulatory deadlines
management is leaning into natural colors ahead of those deadlines. you want adoption to show up before the deadline, not after it.
risk
price versus the $87 midpoint
the stock is already above the midpoint target. that leaves less room for weak volumes, tariff pressure, or a softer mix shift.
Analyst rankings
short-term outlook
below average
momentum score 4 — in human-speak, analysts think the next stretch could be choppy even if the business itself stays stable.
risk profile
average
stability score 3 — this is neither a bunker stock nor a rollercoaster.
chart momentum
top 20%
technical score 2 — the chart looks better than the fundamental ranking, which is another way of saying sentiment has outrun the business a bit.
earnings predictability
70 / 100
predictable enough for a specialty-ingredients name, but not so steady that you should ignore quarterly execution.
source: institutional data
Institutional activity
institutions have been net buying for 2 consecutive quarters — 156 buyers vs. 142 sellers in 3q2025. total institutional holdings: 41.7M shares. net buying for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$57
$117
$95
current price
$87
target midpoint · 9% from current · 3-5yr high: $117
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive